These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24148000)

  • 1. Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
    Muyderman H; Chen T
    Br J Pharmacol; 2014 Apr; 171(8):2191-205. PubMed ID: 24148000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.
    Martin LJ; Gertz B; Pan Y; Price AC; Molkentin JD; Chang Q
    Exp Neurol; 2009 Aug; 218(2):333-46. PubMed ID: 19272377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
    Martin LJ
    Biochim Biophys Acta; 2010 Jan; 1802(1):186-97. PubMed ID: 19651206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
    Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
    J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
    Kawamata H; Manfredi G
    Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
    Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
    PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
    Zhao J; Wang X; Huo Z; Chen Y; Liu J; Zhao Z; Meng F; Su Q; Bao W; Zhang L; Wen S; Wang X; Liu H; Zhou S
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.
    Belosludtseva NV; Matveeva LA; Belosludtsev KN
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
    Bacman SR; Bradley WG; Moraes CT
    Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Shi P; Gal J; Kwinter DM; Liu X; Zhu H
    Biochim Biophys Acta; 2010 Jan; 1802(1):45-51. PubMed ID: 19715760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis.
    Kim HJ; Magranè J; Starkov AA; Manfredi G
    Brain; 2012 Sep; 135(Pt 9):2865-74. PubMed ID: 22961554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.
    Allen SP; Rajan S; Duffy L; Mortiboys H; Higginbottom A; Grierson AJ; Shaw PJ
    Neurobiol Aging; 2014 Jun; 35(6):1499-509. PubMed ID: 24439480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
    Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
    PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mitochondria in amyotrophic lateral sclerosis.
    Smith EF; Shaw PJ; De Vos KJ
    Neurosci Lett; 2019 Sep; 710():132933. PubMed ID: 28669745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.
    Rothstein JD
    Ann Neurol; 2009 Jan; 65 Suppl 1():S3-9. PubMed ID: 19191304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
    Manfredi G; Xu Z
    Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.